Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Christopoulos, I. Katsarou, I. Christopoulos (Athens, Zakynthos, Greece). Anticancer chemotherapy combined with anti-tuberculosis treatment: A systematic review. Eur Respir J 2013; 42: Suppl. 57, 4490

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary tuberculosis and lung cancer: A complex interaction Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Active TB in cancer patients: A missed screening opportunity? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Latent tuberculosis infection and the risk of cancer: A nationwide population-based study Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Progress of treatment delayed testicular tuberculosis: One case Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 The association of lung cancer with active pulmonary tuberculosis. Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Miliary disease of the lung: What is your diagnosis? Source: Annual Congress 2013 –Morphologic imaging Year: 2013 Immuno-allergic reactions to antituberculosis treatment Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Efficacy of preoperative comprehensive pulmonary rehabilitation in patients with lung cancer Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment? Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Interventional management and outcome of lung cancer and cardiac disease. Meta-analytic review Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013